8 patents
Utility
Anti-galectin-9 antibodies and uses thereof
18 Apr 23
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9.
Shohei Koide, George Miller, Akiko Koide, Linxiao Chen, Eric Elenko, Aleksandra Filipovic, Joseph Bolen
Filed: 28 Jun 22
Utility
ANTI-GALECTIN-9 Antibodies and Uses Thereof
27 Oct 22
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9.
Shohei Koide, George Miller, Akiko Koide, Linxiao Chen, Eric Elenko, Aleksandra Filipovic, Joseph Bolen
Filed: 28 Jun 22
Utility
ANTI-GALECTIN-9 Antibodies and Uses Thereof
20 Oct 22
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9.
Shohei Koide, George Miller, Akiko Koide, Linxiao Chen, Eric Elenko, Aleksandra Filipovic, Joseph Bolen
Filed: 28 Jun 22
Utility
Anti-galectin-9 antibodies and uses thereof
16 Aug 22
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9.
Shohei Koide, George Miller, Akiko Koide, Linxiao Chen, Eric Elenko, Aleksandra Filipovic, Joseph Bolen
Filed: 19 Sep 19
Utility
Methods and Compositions for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation
14 Oct 20
The present disclosure provides a method of treating a central nervous system disorder in a patient in need thereof.
Eric ELENKO, Philip E. MURRAY, III, Andrew C. MILLER
Filed: 20 May 20
Utility
Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
29 Jun 20
The present disclosure provides a method of treating a central nervous system disorder in a patient in need thereof.
Eric Elenko, Philip E. Murray, III, Andrew C. Miller
Filed: 17 Jun 19
Utility
Deuterium-enriched Pirfenidone and Methods of Use Thereof
25 Mar 20
Disclosed herein are deuterium-enriched N-Aryl pyridinone compounds, optionally in combination with one or more additional therapeutic agents, pharmaceutical compositions comprising the same, methods of preparation thereof, and methods of use thereof.
Eric Elenko, Michael C. Chen, LuAnn Sabounjian
Filed: 15 Sep 19
Utility
ANTI-GALECTIN-9 Antibodies and Uses Thereof
8 Jan 20
Disclosed herein are anti-Galectin-9 antibodies and methods of using such for inhibiting a signaling pathway mediated by Galectin-9 or eliminating pathologic cells expressing Galectin-9.
Shohei Koide, George Miller, Akiko Koide, Linxiao Chen, Eric Elenko, Aleksandra Filipovic, Joseph Bolen
Filed: 18 Sep 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first